financetom
Business
financetom
/
Business
/
Core Scientific Stock Surges On Acquisition Reports With CoreWeave
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Core Scientific Stock Surges On Acquisition Reports With CoreWeave
Jun 26, 2025 10:54 AM

Shares of Core Scientific Inc. ( CORZ ) are up Thursday following a report suggesting CoreWeave inc. ( CRWV ) is in discussions to acquire the bitcoin mining and hosting company.

What To Know: According to the Wall Street Journal, the two companies are in talks and could finalize a deal in the coming weeks if talks proceed without issue. CoreWeave ( CRWV ) previously made an unsuccessful attempt to acquire Core Scientific ( CORZ ) about a year ago, offering $5.75 per share at the time; a bid that was rejected for undervaluing the business. Core Scientific ( CORZ ) shares now trade at more than double that earlier offer, giving the company a market capitalization of roughly $3.7 billion.

Core Scientific ( CORZ ) operates one of the largest high-powered digital infrastructure platforms in North America focused on bitcoin mining and hosting services. The company has seen growing interest amid a shortage of data center space and power capacity as demand from AI-related workloads continues to rise. It also maintains a significant 12-year hosting partnership with CoreWeave ( CRWV ), delivering large-scale capacity for AI computing operations.

CoreWeave ( CRWV ), which went public in March and is valued at approximately $75 billion, specializes in cloud infrastructure for AI workloads. It serves major clients like Microsoft, its largest customer and acts as a middle layer offering access to Nvidia GPUs for firms such as Meta and IBM.

While Core Scientific ( CORZ ) shares rose on the takeover speculation, CoreWeave's ( CRWV ) stock slipped slightly reflecting typical market reactions in acquisition scenarios where the buyer faces potential integration or financing challenges.

Price Action: Core scientific shares were up 24% at $15.25 and Coreweave ( CRWV ) shares were down 1.13% at $157.80 at the time of writing, according to Benzinga pro.

Read Next:

Trump’s Fed Chairman Shortlist Is In: What Investors Need To Know

Image Via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CDC Updates RSV Shot Recommendation Among the Elderly; Vaccine Makers Mixed Pre-Bell
CDC Updates RSV Shot Recommendation Among the Elderly; Vaccine Makers Mixed Pre-Bell
Jun 27, 2024
07:43 AM EDT, 06/27/2024 (MT Newswires) -- The US Centers for Disease Control said Wednesday it updated its recommendation for the use of respiratory syncytial virus, or RSV, vaccines among elderly people, prioritizing those who are at least 75 years old and those who are at risk of contracting severe RSV. The CDC has updated its RSV vaccination recommendation for...
Market Chatter: ZEEKR Intelligent Technology Sees Surge in Russian Sales as Chinese Brands Become Dominant in Country's EV Market
Market Chatter: ZEEKR Intelligent Technology Sees Surge in Russian Sales as Chinese Brands Become Dominant in Country's EV Market
Jun 27, 2024
07:38 AM EDT, 06/27/2024 (MT Newswires) -- ZEEKR Intelligent Technology ( ZK ) has seen a surge in sales in Russia over the past year, despite lacking official representation in the country, with over 8,000 cars sold since June last year, Reuters reported, citing Irina Frank, head of the Frank-Auto dealership in Moscow. From May 2023 to April 2024, Reuters...
Oncolytics Biotech UP 1.9% In US Premarket Announces
Oncolytics Biotech UP 1.9% In US Premarket Announces "Productive" FDA Type C Meeting on Metastatic Breast Cancer Program
Jun 27, 2024
07:54 AM EDT, 06/27/2024 (MT Newswires) -- Oncolytics Biotech Inc. ( ONCY ) on Thursday said it received productive feedback from its Type C meeting with the U.S. Food and Drug Administration (FDA), for its planned trial for lead candidate pelareorep in HR+/HER2- metastatic breast cancer (mBC). The regulator supports progression-free survival as the primary endpoint of the study, with...
American Lithium Up 3% In US Premarket As Prepares to Commence Pilot Work for Falchani Lithium Project in Peru During H2 2024
American Lithium Up 3% In US Premarket As Prepares to Commence Pilot Work for Falchani Lithium Project in Peru During H2 2024
Jun 27, 2024
07:53 AM EDT, 06/27/2024 (MT Newswires) -- American Lithium ( AMLI ) said Thursday that it plans to commence piloting work for the Falchani lithium project in Peru during the second half of this year following strong results from the latest test work on the flowsheet. According to American Lithium ( AMLI ), Falchani's flowsheet utilizes warm sulfuric acid leaching...
Copyright 2023-2026 - www.financetom.com All Rights Reserved